Amdocs Limited (NASDAQ:DOX) Shares Sold by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. lowered its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 3.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 431,673 shares of the technology company's stock after selling 15,108 shares during the quarter. Bahl & Gaynor Inc. owned 0.38% of Amdocs worth $36,753,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Charles Schwab Investment Management Inc. lifted its holdings in shares of Amdocs by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 213,310 shares of the technology company's stock valued at $18,161,000 after acquiring an additional 6,173 shares during the last quarter. SBI Securities Co. Ltd. purchased a new stake in Amdocs during the fourth quarter valued at approximately $41,000. Jones Financial Companies Lllp bought a new stake in shares of Amdocs in the 4th quarter valued at approximately $36,000. Smartleaf Asset Management LLC boosted its holdings in shares of Amdocs by 199.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 686 shares of the technology company's stock worth $59,000 after purchasing an additional 457 shares during the period. Finally, Fisher Asset Management LLC increased its position in shares of Amdocs by 3.1% during the 4th quarter. Fisher Asset Management LLC now owns 9,095 shares of the technology company's stock valued at $774,000 after purchasing an additional 274 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Amdocs Trading Up 2.2 %

Shares of NASDAQ:DOX traded up $1.99 on Friday, hitting $90.46. 757,972 shares of the company's stock were exchanged, compared to its average volume of 658,404. The business's 50 day simple moving average is $86.27 and its two-hundred day simple moving average is $86.90. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The stock has a market capitalization of $10.21 billion, a price-to-earnings ratio of 20.99, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. Amdocs Limited has a 12 month low of $74.41 and a 12 month high of $94.04.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. The ex-dividend date of this dividend is Monday, March 31st. This is a positive change from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.33%. Amdocs's dividend payout ratio is 48.72%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Oppenheimer raised their price target on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 13th. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th. Finally, Barclays cut their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.